| Literature DB >> 15161564 |
Matthew R Cooperberg1, Jeanette M Broering, David M Latini, Mark S Litwin, Katrine L Wallace, Peter R Carroll.
Abstract
The Cancer of the Prostate Strategic Urologic Research Endeavor (CaPSURE) is a national disease registry of more than 10,000 patients with prostate cancer treated at 31 primarily community-based sites across the country. The database tracks oncologic and health-related quality-of-life outcomes. Because the urologists participating in the project treat according to their usual practices, CaPSURE facilitates the study of trends in disease-management strategies, offering a reflection of "real world" practice patterns. This review highlights key studies during the past several years that document downward risk migration, validates widely used prognostic nomograms, establishes prostate-specific antigen doubling time as a surrogate endpoint for disease-specific mortality, assesses the impact of treatment on patient-reported quality of life, and presents national trends in imaging test use and primary treatment strategies for localized disease.Entities:
Mesh:
Year: 2004 PMID: 15161564 DOI: 10.1007/s11934-004-0033-7
Source DB: PubMed Journal: Curr Urol Rep ISSN: 1527-2737 Impact factor: 2.862